Metal-based anticancer drugs, notably platinum-based such as cisplatin, have a tremendous clinical impact: it is estimated that at least half of all cancer patients are treated with a platinum-based drug. Metal-based Anticancer Agents introduces the main classes of metallodrugs, their possible different biological targets, the major and concepts and methods. The book also provides an overview of the most significant experimental and conceptual progresses made during the last years in the areas of inorganic medicinal chemistry and metallodrug discovery and development. This book will be a valuable resource for experts in the field but also for those wishing to extend their expertise to metal-based cancer drugs.
